The Supreme Court of Victoria rejected a novel, ratcheted Group Costs Order ( GCO) in Peter Collens and Gai Collens ATF the Collens Superannuation Fund v Mineral Resources Limited and Anor preferring ...
If passed, the Treasury Laws Amendment (Genetic Testing Protections in Life Insurance and Other Measures) Bill 2025 will create the following three new licensing exemptions, replacing the current ...
The Federal Government has released exposure draft legislation (the Treasury Laws Amendment (Business Registries Stabilisation and Uplift) Bill 2025 ), accompanying draft regulations and explanatory / ...
This week, the Australian Treasurer enacted new regulations to outlaw excessive pricing by Australian supermarkets. These regulations will come into force on 1 July 2026. The Treasurer announced the ...
He is the leading industry expert in real estate law as well as the application of planning and environmental law, construction law, transaction structuring and project financing to property ...
When ASIC released its Capital Markets Roadmap (REP 823) in November, it foreshadowed the introduction of an “easily-referenced regulatory guidance catalogue” for funds management. That commitment has ...
Top tier practice, renowned for its practical and commercial approach to addressing client needs. The quality, depth and expertise of our team is evidenced by the list of clients we serve including ...
What does it take to turn good intentions into measurable impact and competitive returns? Australia’s latest Benchmarking Impact Report provides a clear answer: the sector is growing rapidly, ...
We can take you through the move from theory to practice and the challenging jump to a commercial law firm, through programs for every stage of your study and beyond. Sometimes it's hard enough to ...
When ASIC released its Capital Markets Roadmap (REP 823) in November, it foreshadowed the introduction of an “easily-ref ...
In a dramatic change to Australian patent law, Australia's Full Federal Court has just held that patents for pharmaceutical formulations are not eligible for patent term extensions (PTE): Otsuka ...